Emma J Jones

✨PROMOTION SPOTLIGHT✨ last but certainly not least, four new team leads! Emma Jones & Erin Bailey will lead IP + OP oncology, while Stacy Prelewicz & Charlotte Wagner will lead IP + OP heme/BMT - all are PharmD & BCOP certified rockstars 🔥✅ #oncopharm #leadership

✨PROMOTION SPOTLIGHT✨ We’ve had meaningful changes within our Huntsman pharmacy leadership team & are excited about the future! First up: Makala Pace, PharmD, BCOP, MBA-promoted to Director in February. She is already making a positive impact for staff & patients! #oncopharm

JUST IN: @US_FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell carcinoma (RCC) following PD1 and VEGF inhibitors! A great day for the field and a new option for our Kidney Cancer patients!!!! Via @ASCO #FDAAlerts @OncoAlert Study presented at @myESMO #ESMO3 by @AlbigesL

Unprecedented times!👉@FDA approves Enfortumab vedotin (EV)+pembrolizumab for metastatic #bladdercancer pts @DrChoueiri is always ahead of us in sharing. I will add the trial results👇 which I just discussed with a colleague 👇@tompowles1 @oncoalert @urotoday @BladderCancerUS

We are recruiting for at least two external candidates so please email RPD @KLratermann with any additional questions and we look forward to hearing from you!